Literature DB >> 11312324

Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation.

Y Peng1, E Falck-Pedersen, K B Elkon.   

Abstract

The innate immune response against replication-defective adenoviruses (Ad) is poorly defined. We and others have previously observed striking differences in the rate at which the Ad vector itself or the virus encoding a variety of transgenes is eliminated in different mouse strains. Here, we report that Ad infection of BALB/ mice is associated with sixfold-higher levels of serum alanine aminotransferase and that Ad transgenes induce two- to threefold-higher levels of intrahepatic NK cells and NK activity compared to C57BL/6 mice. The increase in NK activation in BALB/c mice was associated with approximately 4-fold higher level of mRNA expression of a newly described NKG2 receptor activator, H-60, as well as increased expression of interleukin-12 and gamma interferon mRNAs in BALB/c mice compared to C57BL/6 mice. NK depletion in BALB/c mice or defective NK function in C3H beige mice extended transgene expression compared to their appropriate controls, and attenuation of NK together with CD8 T-cell function had a synergistic effect. These findings indicate that there are intrinsic differences in the innate immune responses of different mouse strains to Ad and Ad transgenes and that NK cells, in cooperation with CD8 T cells, play a pivotal role in the early extinction of transgene expression in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312324      PMCID: PMC114207          DOI: 10.1128/JVI.75.10.4540-4550.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Dealing from the evolutionary pawnshop: how lymphocytes make decisions.

Authors:  S L Reiner; R A Seder
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

3.  NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.

Authors:  M K Slifka; R R Pagarigan; J L Whitton
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

4.  Gene therapy death prompts review of adenovirus vector.

Authors:  E Marshall
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

5.  Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo.

Authors:  Y Peng; E Falck-Pedersen; K B Elkon
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

6.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

7.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

Authors:  A Cerwenka; A B Bakker; T McClanahan; J Wagner; J Wu; J H Phillips; L L Lanier
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

8.  Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

Authors:  M Christ; B Louis; F Stoeckel; A Dieterle; L Grave; D Dreyer; J Kintz; D Ali Hadji; M Lusky; M Mehtali
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

9.  Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.

Authors:  G J Bancroft; G R Shellam; J E Chalmer
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

10.  Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.

Authors:  K W McIntyre; R M Welsh
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  16 in total

1.  Genetic heterogeneity and efficiency of two different methods of adenovirus-mediated gene transfer in a rat liver transplantation model.

Authors:  Kensuke Adachi; Masayuki Fujino; Yusuke Kitazawa; Naoko Funeshima; Xiao-Kang Li
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.

Authors:  Bryan M Burt; George Plitas; Jennifer A Stableford; Hoang M Nguyen; Zubin M Bamboat; Venu G Pillarisetty; Ronald P DeMatteo
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

3.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

4.  Increased sensitivity to staphylococcal enterotoxin B following adenoviral infection.

Authors:  Timur O Yarovinsky; Michael P Mohning; Mary A Bradford; Martha M Monick; Gary W Hunninghake
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.

Authors:  Huang-Ge Zhang; Jinfu Xie; Liang Xu; Pingar Yang; Xin Xu; Sheher Sun; Yongming Wang; David T Curiel; Hui-Chen Hsu; John D Mountz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

7.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Mouse adenovirus type 1 infection of natural killer cell-deficient mice.

Authors:  Amanda R Welton; Lisa E Gralinski; Katherine R Spindler
Journal:  Virology       Date:  2007-12-21       Impact factor: 3.616

10.  Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.

Authors:  Mahtab Moayeri; Jacqueline M Tremblay; Michelle Debatis; Igor P Dmitriev; Elena A Kashentseva; Anthony J Yeh; Gordon Y C Cheung; David T Curiel; Stephen Leppla; Charles B Shoemaker
Journal:  Clin Vaccine Immunol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.